If it wins the federal OK, the company hopes to debut the late-stage drug candidate on the market within the next two years.
from https://www.bizjournals.com/baltimore/news/2017/09/19/md-biotech-expands-hq-in-ramp-up-for-potential.html?ana=RSS%26s=article_search
via http://baltimorecheckbook.tumblr.com/post/165511822872
No comments:
Post a Comment